Company / Current Liabilities per Share
AMICUS THERAPEUTICS, INC. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.80
FY2025
5-year range
$0.50 / $0.80
FY2021-FY2025
Trend
+57.0%
vs FY2024
Sector context
#122 of 210
Health Care
What the data says
At $0.80, AMICUS THERAPEUTICS, INC.'s current liabilities per share ranks #89 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.46 in FY2018 to $0.89 in FY2016.
Based on SEC 10-K filings.
0.80 in FY2025 with a 5-year CAGR of +9.7%.
Increased from $0.60 to $0.80 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +16.9%
- 5-Year CAGR
- +9.7%
- 10-Year CAGR
- -
Sector benchmark
-96.7% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 57.0% year-over-year.
- Ranks #122 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2016.
- Lowest current liabilities per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.80 | +57.0% |
| FY2024 | $0.51 | -15.1% |
| FY2023 | $0.60 | +19.7% |
| FY2022 | $0.50 | -10.5% |
| FY2021 | $0.56 | +11.2% |
| FY2020 | $0.50 | -6.5% |
| FY2019 | $0.54 | +15.6% |
| FY2018 | $0.46 | -5.6% |
| FY2017 | $0.49 | -44.7% |
| FY2016 | $0.89 | +15.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026